Pacific EdgeASX:PEB -6.00%46 PB Ratio is 26.11 as of Jul. 04, 2026, which is 291% above its 10-year median of 6.68. GuruFocus rates ASX:PEB with a GF Score™ of 46/100 and a GF Value™ of A$0.05 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Pacific Edge ranks worse than 97.94% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-04), Pacific Edge's share price is A$0.235. Pacific Edge's Book Value per Share for the quarter that ended in Mar. 2026 was A$0.01. Hence, Pacific Edge's PB Ratio of today is 26.11.
Warning Sign:
Pacific Edge Ltd stock PB Ratio (=30) is close to 3-year high of 31.
The historical rank and industry rank for Pacific Edge's PB Ratio or its related term are showing as below:
ASX:PEB'
s PB Ratio Range Over the Past 10 Years
Min: 0.71 Med: 6.68 Max: 58.1
Current: 28.2
During the past 13 years, Pacific Edge's highest PB Ratio was 58.10. The lowest was 0.71. And the median was 6.68.
ASX:PEB's PB Ratio is ranked worse than 97.94% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.045
vs ASX:PEB: 28.20
During the past 12 months, Pacific Edge's average Book Value Per Share Growth Rate was -68.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -53.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -26.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -4.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pacific Edge was 203.70% per year. The lowest was -53.90% per year. And the median was 0.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Pacific Edge PB Ratio Related Terms
Pacific Edge PB Ratio Historical Data
* Premium members only.
The historical data trend for Pacific Edge's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Pacific Edge's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacific Edge PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's PB Ratio distribution charts can be found below:
* The bar in red indicates where Pacific Edge's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Pacific Edge's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Pacific Edge (ASX:PEB) has a PB Ratio of 26.11 as of Jul. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pacific Edge and its competitors. This is 291% above median its historical median of 6.68. Over the past decade, Pacific Edge's PB Ratio has ranged from 0.71 to 58.10. According to the industry distribution chart, Pacific Edge ranks #190 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 97.9%.
Is Pacific Edge's PB Ratio too high?
Pacific Edge's current PB Ratio of 26.11 is 291% above median its 10-year median of 6.68. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 58.10. The Medical Diagnostics & Research industry median PB Ratio is 2.05. Pacific Edge's value of 26.11 is 1176.8% above this industry median. Based on the distribution chart, Pacific Edge ranks #190 out of 194 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Pacific Edge has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pacific Edge's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Pacific Edge ranks #190 out of 194 companies for PB Ratio. This places Pacific Edge in the lower half of its industry. The industry median PB Ratio is 2.05. Pacific Edge's value of 26.11 is 1176.8% above this benchmark. Historically, Pacific Edge's own PB Ratio has ranged from 0.71 to 58.10 over the past decade. While the company's 10-year median is 6.68 vs. the industry median of 2.05, Pacific Edge has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.05, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pacific Edge's current PB Ratio of 26.11 is 1176.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pacific Edge and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pacific Edge's current PB Ratio is 26.11, which is 291% above median its own 10-year median of 6.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Edge stock overvalued right now?
Based on GuruFocus' analysis, Pacific Edge (ASX:PEB) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.05, compared to a current price of A$0.24 — trading 370% above its estimated fair value. The current PB Ratio is 26.11, which is 291% above median its 10-year median of 6.68 and 1176.8% above the Medical Diagnostics & Research industry median of 2.05. Pacific Edge's overall GF Score™ is 46/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Pacific Edge (ASX:PEB), the current PB Ratio is 26.11 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pacific Edge (ASX:PEB) Overvalued in 2026?
Based on GuruFocus' analysis, Pacific Edge stock appears to be overvalued.
The current stock price of A$0.24 is trading 370% above its estimated GF Value™ of A$0.05.
GuruFocus considers Pacific Edge to be Significantly Overvalued.
Key valuation signals for ASX:PEB:
PB Ratio: 26.11 (291% above median its 10-year median of 6.68)
GF Value™: A$0.05 vs. price of A$0.24 (370% above fair value)
Industry Position: 1176.8% above the Medical Diagnostics & Research median (#190 of 194)
No single metric tells the full story. See the ASX:PEB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pacific Edge Ltd is a New Zealand-based company involved in researching, developing, and commercialising new diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. It operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses internationally; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, which generates maximum revenue, New Zealand, and the Rest of the World.
46GF Score
Get the complete analysis for ASX:PEB
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PEB has been successfully added to your 
